Orthobiologics Market 2025 - Global Industry Insights, Trends, Outlook, And Opportunity Analysis

A growth in the global orthobiologics market is projected on account of the requirement for safer, more effective and
modern orthopedic biologic treatment. The rise in the number of obesity and arthritis cases also fuels the demand for
orthobiologics treatment. The bone graft procedure accounted to be the largest segment in the global orthobiologics
market.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/orthobiologics-market/request-sample
The shifting preference to biological implants from mechanical implants is accelerating the growth of this market.
Another important trend that is estimated to enhance the growth of the market over next eight years is the increase
in funds to improve orthobiologics. Factors such as growing advances in technology, the prevalence of a huge number
of chronic and unidentified diseases, initiatives by the government and rise in life expectation may favorably impact
the market growth. Along with this, the rising incidences of injuries by sports & road accidents and growing awareness
among athletes are also driving the demand for the market.
However, lack of clear reimbursement procedures and rigorous rules may create major hindrances for the
orthobiologics demand in the market. The improvements in developing alternatives for pharmaceuticals, for making
medical treatments more preventive than curative along with the country’s policy for decreasing the deficit in the
budget is expected to negatively impact the global orthobiologics market. Furthermore, high costs for the procedure,
lack of reliable clinical trial data and strict regulations for the approval of orthobiologics products may pose challenges
to the market growth over the forecast period.
The global orthobiologics market has been segmented based on its applications and product types. On the basis of
application, the market been classified into spinal surgery, joint replacement & reconstruction, and trauma surgery.
On the basis of product types, the market has been segmented into bone graft substitutes, bone growth stimulators,
and viscosupplements. The bone graft substitutes have further been segmented into demoralized bone matrix (DBM),
bone morph genic proteins (BMP), bone allografts, and bone autographs. Additionally, viscosupplements has also been
further segmented into single injection viscosupplements, 3-injection viscosupplements, and 5-injection
viscosupplements.
Over the past few years, the viscosupplements segments held the largest market share for orthobiologics on account
of huge demand for knee treatment procedures. It is a very effective pain killer. Viscosupplements are intra-articular
injections made of hyaluronic acid which helps in the treatment of osteoarthritis.
North America held the majority of the global orthobiologics market in the recent past. The high demand in the market
was sustained by increased prevalence of arthritis and obesity in the region, rising demand for the treatment of various
diseases such as osteoarthritis and spinal injuries. However, over the next eight years, Asia-Pacific is projected to
witness the highest rate of growth for orthobiologics market. This growth will be majorly driven by the Indian and
Chinese market on account of a huge number of untapped patient population, economical cost, and medical tourism.